Healthcare futurist and keynote speaker on AI in healthcare, women’s health, pharma strategy and global healthcare growth
Consider for
Healthcare and life sciences leaders, pharma and medtech teams, investors and organizations planning future care
Plan together
Share your audience, preferred format and event date. We will confirm fit and availability.
Keynote topics
Six keynotes for your audience
Explore Reenita’s keynote topics and audience takeaways. Session emphasis, timing and regional context are tailored during planning.
01
Healthcare 2050: The Megatrends That Will Redraw the World
Explore how aging populations, AI, robotics, climate pressures and geopolitics could reshape healthcare. Reenita connects these long term forces to the strategic decisions leaders face today.
Audience takeaways
The five megatrends that will define healthcare in 2050, and which ones are already moving faster than expected
How AI and robotics could fill the global health workforce gap, and where they will fall short
Why climate change is becoming a core health and business risk, not just a sustainability issue
A simple framework to future-proof their strategy, portfolio or health system starting now
The Algorithm Gap: Why AI Is Failing Women, and How to Fix It
Examine how gaps in research and health data can affect AI for women’s health. Reenita explores implications for technology development, investment and policy, with the session tailored to the audience’s region.
Audience takeaways
The three layers of the data gap, and how to spot bias in an AI tool before it reaches patients
The conditions where women are most underserved, from heart disease and autoimmune disorders to mental health and menopause
The policy changes that would make the biggest difference, such as requiring sex-disaggregated data in publicly funded research
Why owning better, more representative data will be the real competitive edge in health tech
Pharma's Great Reset: Patent Cliffs, Price Pressure and the China Factor
Explore how patent expirations, pricing pressure, trade policy and China’s role in drug development are reshaping pharma strategy. Reenita considers the implications for portfolios, partnerships and growth.
Audience takeaways
Which companies and therapy areas are most exposed to the patent cliff, and how leaders are filling the gap
What US drug pricing reforms and tariffs mean for global pricing, launches and manufacturing
How China went from copycat to innovation partner, and what that means for biotech deals and R&D
The strategic moves that will separate winners from losers in pharma through 2030
The New Map of Global Healthcare: Where Growth Is Moving Next
Consider healthcare growth opportunities across India, Southeast Asia, the Gulf, Africa and Latin America. Reenita explores market entry, local manufacturing and partnerships suited to different health systems.
Audience takeaways
Which markets will drive healthcare growth over the next decade, and what makes each one different
How supply chains are being redrawn, and what local manufacturing means for access and cost
Why so many market-entry pilots stall, and the steps that turn them into system-wide adoption
How to build partnerships with governments, payers and local players that last
Health Beyond Healthcare: Who Will Really Own Your Health?
Explore how technology companies, retailers, employers and consumer brands are moving into health. Reenita examines what these changing relationships mean for healthcare organizations and their partners.
Audience takeaways
Which non-healthcare players are gaining ground in health, and the lessons from those that have pulled back
How AI assistants are becoming the new “front door” to health for millions of people
Where the biggest partnership opportunities lie between traditional healthcare and consumer brands
How to stay relevant as health moves into homes, workplaces and everyday products
The Patient of the Future: How Gen Z and Gen Alpha Will Rewrite the Patient Experience
Examine how Gen Z and Gen Alpha may reshape expectations of health information and services. Reenita explores AI assistants, trust, misinformation and the continuing role of human care.
Audience takeaways
How Gen Z and Gen Alpha find, judge and use health information differently from any generation before them
What AI agents and bots will take over in the patient journey, and where human care still matters most
The new risks, from health misinformation on social media to privacy and over-reliance on AI
How to redesign services, brands and communication for the healthcare consumer of 2035
Connecting healthcare trends with strategic decisions
Reenita Das is a healthcare futurist and strategist and Founder and Managing Director of NXT Horizon. She brings three decades of healthcare experience and previously served as a partner at Frost & Sullivan. Her keynotes explore healthcare megatrends, women’s health and AI, pharma strategy, global markets and changing patient expectations.
Her work connects long term healthcare trends with practical decisions about investment, growth, partnerships and access to care.
Topics include Healthcare 2050: The Megatrends That Will Redraw the World; The Algorithm Gap: Why AI Is Failing Women, and How to Fix It; Pharma's Great Reset: Patent Cliffs, Price Pressure and the China Factor; The New Map of Global Healthcare: Where Growth Is Moving Next; Health Beyond Healthcare: Who Will Really Own Your Health?; The Patient of the Future: How Gen Z and Gen Alpha Will Rewrite the Patient Experience.
Earlier interviews may show her former Frost & Sullivan title.
Formats for your event
Keynotes, panels, half or full day moderation, and workshop chairing for internal teams and conferences. Scope and availability confirmed for each event.
Start a conversation
Bring Reenita into the conversation.
Share your event date, audience and the conversation you want to start.
